OMX Nordic 40
2 322,00
|
23,78
|
1,03%
|
Analysen zu OMX Nordic 40-Werten
24.02.25 | ABB Neutral | UBS AG | |
24.02.25 | ABB Sector Perform | RBC Capital Markets | |
24.02.25 | Novo Nordisk Buy | UBS AG | |
24.02.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
24.02.25 | Volvo AB Buy | Goldman Sachs Group Inc. | |
20.02.25 | Nokia Overweight | JP Morgan Chase & Co. | |
20.02.25 | AstraZeneca Outperform | Bernstein Research | |
20.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
20.02.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
19.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
19.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
18.02.25 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
17.02.25 | Novo Nordisk Buy | UBS AG | |
17.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
13.02.25 | AstraZeneca Buy | UBS AG | |
12.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
12.02.25 | AstraZeneca Hold | Deutsche Bank AG | |
12.02.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
11.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
11.02.25 | ABB Underperform | Bernstein Research | |
11.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
11.02.25 | AstraZeneca Outperform | Bernstein Research | |
11.02.25 | ABB Neutral | Goldman Sachs Group Inc. | |
10.02.25 | Novo Nordisk Buy | UBS AG | |
10.02.25 | Nokia Overweight | JP Morgan Chase & Co. | |
10.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
10.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
07.02.25 | AstraZeneca Halten | DZ BANK | |
07.02.25 | ABB Kaufen | DZ BANK | |
07.02.25 | Volvo AB Sector Perform | RBC Capital Markets | |
07.02.25 | A.P. Moeller - Maersk A-S Underperform | Bernstein Research | |
07.02.25 | AstraZeneca Hold | Deutsche Bank AG | |
07.02.25 | Novo Nordisk Buy | UBS AG | |
06.02.25 | Novo Nordisk Halten | DZ BANK | |
06.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
06.02.25 | AstraZeneca Neutral | UBS AG | |
06.02.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
06.02.25 | A.P. Moeller - Maersk A-S Neutral | UBS AG | |
06.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. |